NCT05128292View on ClinicalTrials.gov

Effect of CoQ10 Plus Selenium Supplementation on Clinical Outcomes and Biochemical Markers in ME/CFS (CoSeME Study)

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

November 30, 2018

Conditions
Myalgic Encephalomyelitis
Interventions
DIETARY_SUPPLEMENT

CoQ10 plus Selenium

400 mg/day CoQ10 soft gel capsula (Bio-Quinone active 100 mg b.i.d) plus 200 microgram organic selenium yeast tablet (SelenoPrecise 100 microgram b.i.d.) over 8 weeks

Trial Locations (1)

08035

Vall d'Hebron University Hospital, Barcelona

Sponsors

Collaborators (1)

Pharma Nord
All Listed Sponsors
collaborator

Pharma Nord

INDUSTRY

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT05128292 - Effect of CoQ10 Plus Selenium Supplementation on Clinical Outcomes and Biochemical Markers in ME/CFS (CoSeME Study) | Biotech Hunter | Biotech Hunter